Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 7 studies | 72% ± 26% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 6 studies | 30% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| heart | 100% | 26388.85 | 857 / 861 | 0% | 0 | 0 / 0 |
| muscle | 96% | 2528.85 | 774 / 803 | 0% | 0 | 0 / 0 |
| prostate | 5% | 31.14 | 13 / 245 | 4% | 0.27 | 21 / 502 |
| adrenal gland | 4% | 15.92 | 10 / 258 | 3% | 0.35 | 6 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.06 | 1 / 45 |
| liver | 0% | 0 | 0 / 226 | 2% | 0.06 | 9 / 406 |
| thymus | 2% | 7.68 | 13 / 653 | 0% | 0.00 | 1 / 605 |
| blood vessel | 2% | 79.88 | 24 / 1335 | 0% | 0 | 0 / 0 |
| breast | 1% | 14.34 | 6 / 459 | 0% | 0.00 | 2 / 1118 |
| ovary | 0% | 0 | 0 / 180 | 1% | 0.03 | 5 / 430 |
| brain | 1% | 6.08 | 23 / 2642 | 0% | 0.01 | 2 / 705 |
| esophagus | 0% | 0.93 | 6 / 1445 | 1% | 0.01 | 1 / 183 |
| uterus | 0% | 0 | 0 / 170 | 1% | 0.15 | 4 / 459 |
| lung | 0% | 30.99 | 2 / 578 | 0% | 0.01 | 5 / 1155 |
| stomach | 0% | 0 | 0 / 359 | 1% | 0.01 | 2 / 286 |
| skin | 0% | 0.93 | 4 / 1809 | 0% | 0.00 | 1 / 472 |
| pancreas | 0% | 0.96 | 1 / 328 | 0% | 0 | 0 / 178 |
| adipose | 0% | 2.61 | 3 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 0% | 0.69 | 2 / 966 | 0% | 0 | 0 / 527 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 0% | 0 | 0 / 901 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0042761 | Biological process | very long-chain fatty acid biosynthetic process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0016020 | Cellular component | membrane |
| GO_0016491 | Molecular function | oxidoreductase activity |
| GO_0016627 | Molecular function | oxidoreductase activity, acting on the CH-CH group of donors |
| Gene name | TECRL |
| Protein name | Trans-2,3-enoyl-CoA reductase like Trans-2,3-enoyl-CoA reductase-like (EC 1.3.1.-) (Steroid 5-alpha-reductase 2-like 2 protein) |
| Synonyms | SRD5A2L2 |
| Description | |
| Accessions | ENST00000509536.1 H0Y9F0 ENST00000511997.1 E9PD39 D6RBZ3 ENST00000507440.5 Q5HYJ1 ENST00000381210.8 |